Literature DB >> 18573427

Underuse of surgical resection for localized, non-small cell lung cancer among whites and African Americans in South Carolina.

Nestor F Esnaola1, Mulugeta Gebregziabher, Kelly Knott, Chris Finney, Gerard A Silvestri, Carolyn E Reed, Marvella E Ford.   

Abstract

BACKGROUND: Early studies using Medicare data reported racial disparities in surgical treatment of localized, non-small cell lung cancer. We analyzed the independent effect of race on use of surgical resection in a recent, population-based sample of patients with localized non-small cell lung cancer, controlling for comorbidity and socioeconomic status.
METHODS: All cases of localized non-small cell lung cancer reported to our state Cancer Registry between 1996 and 2002 were identified and linked to the Inpatient/Outpatient Surgery Files and 2000 Census. Comorbidity (Romano-Charlson index) was calculated using administrative data codes. Educational level and income were estimated using census data. Characteristics of white and African American patients were compared using chi(2) tests. Odds ratios of resection and 95% confidence intervals were calculated using logistic regression.
RESULTS: We identified 2,506 white and 550 African American patients. African Americans were more likely to be younger, male, not married, less educated, poor, and uninsured or covered by Medicaid (all p < 0.0001), and to reside in rural communities (p = 0.0005). Use of surgical resection across races was lower than previously reported, and African Americans were significantly less likely to undergo surgery compared with whites (44.7% versus 63.4%; p < 0.0001). Even after controlling for sociodemographics, comorbidity, and tumor factors, the adjusted odds ratio for resection for African Americans was 0.43 (95% confidence interval, 0.34 to 0.55).
CONCLUSIONS: Underuse of surgical resection for localized, non-small cell lung cancer is a persistent problem, particularly among African Americans. Further studies are urgently needed to identify the patient-, physician-, and health system-related factors underlying these observations and optimize resection rates for non-small cell lung cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18573427      PMCID: PMC4161276          DOI: 10.1016/j.athoracsur.2008.02.072

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  19 in total

1.  Racial differences in the treatment of early-stage lung cancer.

Authors:  P B Bach; L D Cramer; J L Warren; C B Begg
Journal:  N Engl J Med       Date:  1999-10-14       Impact factor: 91.245

Review 2.  Racial and ethnic disparities in the receipt of cancer treatment.

Authors:  Vickie L Shavers; Martin L Brown
Journal:  J Natl Cancer Inst       Date:  2002-03-06       Impact factor: 13.506

Review 3.  Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the Public Health Disparities Geocoding Project.

Authors:  Nancy Krieger; Jarvis T Chen; Pamela D Waterman; Mah-Jabeen Soobader; S V Subramanian; Rosa Carson
Journal:  Am J Epidemiol       Date:  2002-09-01       Impact factor: 4.897

4.  Sociodemographic determinants of cancer treatment health literacy.

Authors:  Ted Gansler; S Jane Henley; Kevin Stein; Eric J Nehl; Carol Smigal; Edwin Slaughter
Journal:  Cancer       Date:  2005-08-01       Impact factor: 6.860

5.  Ethnic/racial disparities in hospital procedure volume for lung resection for lung cancer.

Authors:  Charles J Neighbors; Michelle L Rogers; Edmond D Shenassa; Christopher N Sciamanna; Melissa A Clark; Scott P Novak
Journal:  Med Care       Date:  2007-07       Impact factor: 2.983

6.  Who gets chemotherapy for metastatic lung cancer?

Authors:  C C Earle; L N Venditti; P J Neumann; R D Gelber; M C Weinstein; A L Potosky; J C Weeks
Journal:  Chest       Date:  2000-05       Impact factor: 9.410

7.  Detecting survival effects of socioeconomic status: problems in the use of aggregate measures.

Authors:  H P Greenwald; N L Polissar; E F Borgatta; R McCorkle
Journal:  J Clin Epidemiol       Date:  1994-08       Impact factor: 6.437

8.  Differences in initial treatment patterns and outcomes of lung cancer in the elderly.

Authors:  T J Smith; L Penberthy; C E Desch; M Whittemore; C Newschaffer; B E Hillner; D McClish; S M Retchin
Journal:  Lung Cancer       Date:  1995-12       Impact factor: 5.705

9.  Comparison of prognostic factors and survival among black patients and white patients treated with irradiation for non-small-cell lung cancer.

Authors:  M V Graham; L M Geitz; R Byhardt; S Asbell; M Roach; R C Urtasun; W J Curran; P Lattin; A H Russell; J D Cox
Journal:  J Natl Cancer Inst       Date:  1992-11-18       Impact factor: 13.506

10.  Social factors, treatment, and survival in early-stage non-small cell lung cancer.

Authors:  H P Greenwald; N L Polissar; E F Borgatta; R McCorkle; G Goodman
Journal:  Am J Public Health       Date:  1998-11       Impact factor: 9.308

View more
  29 in total

1.  Perceptions of support among older African American cancer survivors.

Authors:  Jill B Hamilton; Charles E Moore; Barbara D Powe; Mansi Agarwal; Pamela Martin
Journal:  Oncol Nurs Forum       Date:  2010-07       Impact factor: 2.172

2.  "Cutting" on cancer: attitudes about cancer spread and surgery among primary care patients in the U.S.A.

Authors:  Aimee James; Christine M Daley; K A Greiner
Journal:  Soc Sci Med       Date:  2011-10-05       Impact factor: 4.634

3.  Disparities in lung cancer staging with positron emission tomography in the Cancer Care Outcomes Research and Surveillance (CanCORS) study.

Authors:  Michael K Gould; Ellen M Schultz; Todd H Wagner; Xiangyan Xu; Sharfun J Ghaus; Robert B Wallace; Dawn Provenzale; David H Au
Journal:  J Thorac Oncol       Date:  2011-05       Impact factor: 15.609

4.  Racial and Ethnic Differences in the Epidemiology and Genomics of Lung Cancer.

Authors:  Matthew B Schabath; Douglas Cress; Teresita Munoz-Antonia
Journal:  Cancer Control       Date:  2016-10       Impact factor: 3.302

5.  Racial Differences in Tobacco Cessation and Treatment Usage After Lung Screening: An Examination of the National Lung Screening Trial.

Authors:  Pallavi Kumar; Ilana F Gareen; Christopher Lathan; JoRean D Sicks; Giselle K Perez; Kelly A Hyland; Elyse R Park
Journal:  Oncologist       Date:  2015-12-28

6.  Disparities between blacks and whites in tobacco and lung cancer treatment.

Authors:  Elyse R Park; Sandra J Japuntich; Lara Traeger; Sheila Cannon; Hannah Pajolek
Journal:  Oncologist       Date:  2011-09-29

7.  Racial differences in the perception of lung cancer: the 2005 Health Information National Trends Survey.

Authors:  Christopher S Lathan; Cassandra Okechukwu; Bettina F Drake; Gary G Bennett
Journal:  Cancer       Date:  2010-04-15       Impact factor: 6.860

8.  Lung cancer survival among black and white patients in an equal access health system.

Authors:  Li Zheng; Lindsey Enewold; Shelia H Zahm; Craig D Shriver; Jing Zhou; Aizen Marrogi; Katherine A McGlynn; Kangmin Zhu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-08-16       Impact factor: 4.254

Review 9.  Lung cancer care: the impact of facilities and area measures.

Authors:  Christopher S Lathan
Journal:  Transl Lung Cancer Res       Date:  2015-08

10.  Persistence of racial disparities in early-stage lung cancer treatment.

Authors:  Andrea Wolf; Naomi Alpert; Benjamin V Tran; Bian Liu; Raja Flores; Emanuela Taioli
Journal:  J Thorac Cardiovasc Surg       Date:  2018-12-11       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.